The immune system, Part 2: Myasthenia gravis.
Stephens
A
A
Radcliffe Infirmary, Oxford.
D003131:Combined Modality Therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009157:Myasthenia Gravis / Q000276:immunology* / Q000503:physiopathology / Q000628:therapy; D010951:Plasma Exchange; D013934:Thymectomy
D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents